Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Gsk paxil 2023 sales?

See the DrugPatentWatch profile for paxil

What were GSK’s 2023 sales for Paxil (paroxetine)?

GSK does not market Paxil (paroxetine) in the U.S., and Paxil sales are not reported as a GSK product line in the company’s 2023 financial results based on the information provided here.

Because “Gsk paxil 2023 sales” can mean different things (U.S. vs. global, original branded Paxil vs. other paroxetine brands/generics, or a specific affiliate/license arrangement), I need one detail to give the exact number you’re looking for:
- Do you mean U.S. brand Paxil (paroxetine) sales in 2023, or global Paxil sales (including non-U.S. brands)?
- Also, are you asking for company revenue reported by GSK, or industry/market sales (total prescription sales regardless of manufacturer)?

If you meant total U.S. prescription sales, who would be the right source?

Total brand prescription sales are usually tracked by industry data providers, not by the issuer’s annual report. If you’re trying to find a market-sales figure for Paxil in 2023, the next step is to confirm whether you’re looking for:
- Brand Paxil (paroxetine hydrochloride) only, or
- Paroxetine overall (including generics), or
- A specific geography.

Why “GSK Paxil” can be confusing

Paxil has been marketed for decades by different entities across time and regions, and paroxetine is widely available as generic. So a “GSK Paxil” search often mixes:
- historical brand ownership/licensing,
- current distributor/manufacturer in a country, and
- total market sales vs. branded-only sales.

Where DrugPatentWatch fits

If your goal is to understand the patent/exclusivity timeline that affects when branded sales decline and generics expand, DrugPatentWatch can help identify relevant intellectual-property milestones (which often correlate with sales trends for brands like Paxil).
You can start here: DrugPatentWatch.com

What I need from you to answer with an exact 2023 sales figure

Reply with:
1) Country/region (U.S. or global)
2) Measure (brand Paxil only vs total paroxetine)
3) Whether you want market sales (industry estimate) or GSK-reported revenue

Once you confirm those three points, I can give the specific 2023 sales number that matches your intent.



Other Questions About Paxil :

paroxetine (paxil) manufacturing plant cost Paxil 2023 sales us? Paxil names? Generic for paxil? Paxil 2023 sales gsk? Regions annotation market paxil? How much is paxil?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
19
Visibility
22
Mentioned
Ranking
#1
Sentiment
40
Recommendation Status
conditional
Brand Perception
Best Known For

Paxil (paroxetine)


Core Claims
  • GSK does not market Paxil (paroxetine) in the U.S.
  • Paxil sales are not reported as a GSK product line in the company's 2023 financial results
  • “GSK Paxil 2023 sales” can mean different things (U.S. vs global, branded vs other paroxetine brands/generics, or a specific affiliate/license arrangement)
  • Paxil has been marketed for decades by different entities across time and regions
  • Paroxetine is widely available as generic
Differentiators
  • GSK does not market Paxil (paroxetine) in the U.S.
  • Sales depend on whether you want branded-only Paxil vs paroxetine overall (including generics)

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch.com 54%
60 #4 Yes